Pronto for Patient Blood Management
NCT03586141 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1129
Last updated 2019-02-19
Summary
The concept of Patient Blood Management requires preoperative diagnostic of anemia. To avoid the harmful procedure of venous puncture for drawing a blood sample, noninvasive measurement of hemoglobin has been developed. However noninvasive measurement of hemoglobin has yet been not accurate enough to replace invasive hemoglobin measurement. This study investigates if a noninvasive measurement tool can serve as a screening tool to find out for which patients invasive measurement of hemoglobin is necessary.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Pronto® hemoglobin measurement tool
All patients who are planned to undergo elective surgery come to the preoperative anesthetic ambulance. They are all measured by the Pronto® hemoglobin measurement tool
Sponsors & Collaborators
-
Johannes Gutenberg University Mainz
lead OTHER
Principal Investigators
-
Eva Wittenmeier, MD · Johannes Gutenberg University Centre, department of anaesthesiology, Langenbeckstraße 1, 55131 Mainz, Germany
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-07-22
- Primary Completion
- 2018-11-30
- Completion
- 2018-11-30
Countries
- Germany
Study Locations
More Related Trials
-
The Benefits of a Preoperative Anemia Management Program
NCT01888003 ·Status: TERMINATED ·Phase: NA
-
The Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients
NCT03286712 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Undergoing Orthopedic Surgery and Who Have Low Hematocrit Levels (the Percent of Red Blood Cells in Whole Blood)
NCT00270114 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevalence of Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis Patients in Assiut University Hospital
NCT06053866 ·Status: NOT_YET_RECRUITING
-
The Effect of Epogen and Venofer Dosing Management on Hemoglobin Stability
NCT01975844 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Observational Study of Erythropoietin-Iron Interaction in Anemia of Renal Disease
NCT01719146 ·Status: COMPLETED
-
Erythropoietin And/Or Iron Sucrose For Perioperative Anemia Management In Hip and Knee Arthroplasty
NCT03917394 ·Status: UNKNOWN
-
Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery
NCT01265680 ·Status: COMPLETED ·Phase: NA
-
Practical Anemia Bundle for SusTained Blood Recovery
NCT05167734 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
NCT01736215 ·Status: TERMINATED
-
A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy
NCT00002071 ·Status: COMPLETED ·Phase: NA
-
Predictors of Response to Iron and Erythropoietin Stimulating Agents
NCT03658876 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intravenous Iron Repletion on Renal Function in Patients With Iron Deficiency and Acute Kidney Injury
NCT05960227 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor
NCT00359840 ·Status: COMPLETED ·Phase: PHASE2
-
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
NCT02930850 ·Status: COMPLETED ·Phase: NA
-
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
NCT00557817 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assess Functional Outcomes in Anemic, Critically Ill, Trauma Patients When Taking Epoetin Alfa
NCT00210626 ·Status: TERMINATED ·Phase: PHASE2
-
Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery
NCT01423955 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Safety and Effectiveness of Epoetin Alfa in Facilitating Self-donation of Blood Before Surgery in Patients Who Are Not Anemic and Who Will be Undergoing Orthopedic or Heart and Blood Vessel Surgery
NCT00270075 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia
NCT03528564 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.
NCT00364260 ·Status: COMPLETED ·Phase: PHASE3
-
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
NCT03128853 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.
NCT00270140 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia
NCT00210795 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.
NCT00269971 ·Status: WITHDRAWN ·Phase: PHASE3